Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

NCT03729674 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT03729674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03729674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Observational
Overall status
Unknown status
Start date
November 26, 2018
Completion date
December 31, 2022
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, crohn's disease, rheumatoid arthritis, ulcerative colitis